Sign inJoin waitlistJoin the waitlist

DE

Don Eslin

Physician · BayCare Health System

Credentials: · ·

History

BayCare Health System
2023–Present

Hematology and Medical Oncology
2000–2003
Internal Medicine
1997–2000
Marshall University - Joan C. Edwards School of Medicine
1993–1997

Research

Cholinergic depletion prevents expansion of topographic maps in somatosensory cortex
Proceedings of the National Academy of Sciences of the United States of America · 1991 · Last of 3 authors · 155 citations
Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes
Nature Biotechnology · 2003 · 154 citations
Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin
Blood · 2004 · First of 9 authors · 135 citations

Deanna Mitchell
10 papers
Jacqueline Kraveka
10 papers
William Ferguson
10 papers
William Roberts
10 papers
R Wada
8 papers
Giselle Sholler
7 papers
RS
Robert Sutphin
7 papers
Valerie Brown
7 papers
Javier Oesterheld
6 papers
JR
Jawhar Rawwas
6 papers
MI
Michael Isakoff
5 papers
Peter Zage
5 papers

Clinical trials

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Study chair · Terminated · Phase 1, Phase 2
Giselle Sholler
2011–2014
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Site PI · Recruiting · Phase 2
Milton S. Hershey Medical Center
2026–2036
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Site PI · Recruiting · Phase 1, Phase 2
Milton S. Hershey Medical Center
2026–2035
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028